Records 1 - 2
| Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK.
Cancer research 2003 Nov 63 (22): 8057-61.
Wang Haijian, Tan Wen, Hao Bingtao, Miao Xiaoping, Zhou Gangqiao, He Fuchu, Lin Dongx
| Genetic polymorphisms of the human CYP2A13 gene: identification of single-nucleotide polymorphisms and functional characterization of an Arg257Cys variant.
The Journal of pharmacology and experimental therapeutics 2002 Aug 302 (2): 416-23.
Zhang Xiuling, Su Ting, Zhang Qing-Yu, Gu Jun, Caggana Michele, Li Hongming, Ding Xinx